PRECISION BIOSCIENCES INC — Director's Dealing 2022

Oct 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-10-15

Reporting Person: Amoroso Michael (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-15	Common Stock	M	24208	—	Acquired	24208	Direct
2022-10-17	Common Stock	S	11006	$1.32	Disposed	13202	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-15	Restricted Stock Units	$	M	24208	Disposed		Common Stock (24208)	Direct

Footnotes

F1: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on October 15, 2022.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

F4: On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022.